<strong>Current status and risk factors for the prevention of oxaliplatin-based moderate emetic chemotherapy-induced nausea and vomiting in patients with gastrointestinal cancer</strong>

doi:10.3781/j.issn.1000-7431.2021.2105-0348

PDF(931 KB)

Tumor ›› 2021, Vol. 41 ›› Issue (07) : 487-503. DOI: 10.3781/j.issn.1000-7431.2021.2105-0348

Current status and risk factors for the prevention of oxaliplatin-based moderate emetic chemotherapy-induced nausea and vomiting in patients with gastrointestinal cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 41(07): 487-503 https://doi.org/10.3781/j.issn.1000-7431.2021.2105-0348

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(931 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Accepted	Published
2021-05-31	2021-07-15	2021-07-25
Issue Date
2021-07-25

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS